The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...
“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Despite millions of cases of norovirus in the U.S. each year—and a current surge in outbreaks—there is still no vaccine for ...
Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people ...
The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...
There is currently no vaccine for norovirus because of its many strains and the elusive nature of how the virus evolves. The closest norovirus vaccine is a Moderna trial wrapping up in 2027 ...
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...